ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
G. Chad Hughes
Shankha S. Biswas
James E. Lowe
Brian H. Annex
Kevin P. Landolfo
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hughes, G. C.
Right arrow Articles by Landolfo, K. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hughes, G. C.
Right arrow Articles by Landolfo, K. P.
Related Collections
Right arrow Coronary disease

Ann Thorac Surg 2004;77:812-818
© 2004 The Society of Thoracic Surgeons

Original article: cardiovascular

Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF

G. Chad Hughes, MDa*, Shankha S. Biswas, MDa, Bangliang Yin, MDa, R. Edward Coleman, MDc, Timothy R. DeGrado, PhDc, Carolyn K Landolfo, MDb, James E. Lowe, MDa, Brian H. Annex, MDb, Kevin P. Landolfo, MDa

a Departments of Surgery and Medicine, Divisions of Cardiovascular and Thoracic Surgery, Duke University Medical Center, Durham, NC, USA
b Department of Cardiology, Duke University Medical Center, Durham, NC, USA
c Department of Radiology, Duke University Medical Center, Durham, North Carolina, USA

Accepted for publication September 8, 2003.

* Address reprint requests to Dr Hughes, Box 31224, Duke University Medical Center, Durham, NC 27710, USA
e-mail: chadh{at}duke.edu

BACKGROUND: Both vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) have been used in preclinical studies to induce new blood vessel growth in ischemic cardiac muscle with promising results. However, clinical trials have been much less convincing and further work is needed. This study expands on prior work by comparing the long-term proangiogenic effects of direct intramyocardial (IM) injection of bFGF, as well as IM and intravenous (IV) VEGF in a porcine model of chronic hibernating myocardium.

METHODS: Mini-swine with proximal 90% left circumflex (LCx) coronary stenosis subtending chronically ischemic, viable (hibernating) myocardium by positron emission tomography (PET) and dobutamine stress echocardiography (DSE) were randomized to IM bFGF (n = 5), IM VEGF165 (n = 5), IV VEGF165 (n = 5), IM vehicle (n = 5), or sham redo-thoracotomy (n = 4). The bFGF protein was administered in a total dose of 1.35 µg divided into 30 IM injections. IM VEGF165 protein was administered in a total dose of 15 µg/kg divided into 30 injections; IV VEGF165 was given at a dose of 50 ng · kg-1 · min-1 for 200 minutes at three 72-hour intervals (30 µg/kg total dose). After 3 and 6 months the PET and DSE studies were repeated, and the animals were sacrificed for tissue vascular density and angiogenic protein analysis.

RESULTS: Myocardial blood flow (MBF) by PET was significantly improved 3 months posttreatment in the IM bFGF and IM VEGF165 groups, differences that were sustained at 6 months. There was no significant increase in MBF 3-months posttreatment in the IV VEGF165 group; however, at 6 months MBF was significantly improved. No change in MBF was seen in the IM vehicle or sham groups. Regional wall motion at rest and peak stress in the LCx region demonstrated small but statistically significant improvements by 6 months in the IM bFGF and IV VEGF165 groups only; no improvement was seen in the IM VEGF165, IM vehicle, or sham groups. Quantitative vascular density was significantly increased in the LCx regions of all treatment groups (IM bFGF, IM VEGF165, IV VEGF165) 6-months postoperatively. No significant increase in LCx region myocardial bFGF or VEGF protein levels was seen in the treated animals at 6 months.

CONCLUSIONS: The IM bFGF, IM VEGF165, and IV VEGF165 all improve regional perfusion and vascular density 6-months posttherapy in the animal model utilized. Functional improvements were less consistent. Both bFGF and VEGF165 may be useful therapies for improving regional perfusion in chronically ischemic myocardium, although combination therapy with additional growth factors or cellular therapies may be necessary if concomitant improvements in function are to be seen.




This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
M. Boodhwani, P. Voisine, M. Ruel, N. R. Sodha, J. Feng, S.-H. Xu, C. Bianchi, and F. W. Sellke
Comparison of vascular endothelial growth factor and fibroblast growth factor-2 in a swine model of endothelial dysfunction
Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 645 - 650.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. J. Mondrinos, S. Koutzaki, P. I. Lelkes, and C. M. Finck
A tissue-engineered model of fetal distal lung tissue
Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L639 - L650.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. K. Trousdale, S. V. Pollak, J. Klein, L. Lobel, Y. Funahashi, N. Feirt, and J. W. Lustbader
Single-Chain Bifunctional Vascular Endothelial Growth Factor (VEGF)-Follicle-Stimulating Hormone (FSH)-C-Terminal Peptide (CTP) Is Superior to the Combination Therapy of Recombinant VEGF plus FSH-CTP in Stimulating Angiogenesis during Ovarian Folliculogenesis
Endocrinology, March 1, 2007; 148(3): 1296 - 1305.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. J. van Amerongen, M. C. Harmsen, N. van Rooijen, A. H. Petersen, and M. J.A. van Luyn
Macrophage Depletion Impairs Wound Healing and Increases Left Ventricular Remodeling after Myocardial Injury in Mice
Am. J. Pathol., March 1, 2007; 170(3): 818 - 829.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
Y. Liu, L. Sun, Y. Huan, H. Zhao, and J. Deng
Effects of basic fibroblast growth factor microspheres on angiogenesis in ischemic myocardium and cardiac function: analysis with dobutamine cardiovascular magnetic resonance tagging.
Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 103 - 107.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
A. Schmidt, D. Ladage, T. Schinkothe, U. Klausmann, C. Ulrichs, F.-J. Klinz, K. Brixius, S. Arnhold, B. Desai, U. Mehlhorn, et al.
Basic Fibroblast Growth Factor Controls Migration in Human Mesenchymal Stem Cells
Stem Cells, July 1, 2006; 24(7): 1750 - 1758.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
K. Azarnoush, A. Maurel, L. Sebbah, C. Carrion, A. Bissery, C. Mandet, J. Pouly, P. Bruneval, A. A. Hagege, and P. Menasche
Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1{alpha}
J. Thorac. Cardiovasc. Surg., July 1, 2005; 130(1): 173 - 179.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Simons
Angiogenesis: Where Do We Stand Now?
Circulation, March 29, 2005; 111(12): 1556 - 1566.
[Full Text] [PDF]

Home page
 FASEB J.Home page
J. Smith, R. E. Kontermann, J. Embleton, and S. Kumar
Antibody phage display technologies with special reference to angiogenesis
FASEB J, March 1, 2005; 19(3): 331 - 341.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. C. Wu, I. Y. Chen, Y. Wang, J. R. Tseng, A. Chhabra, M. Salek, J.-J. Min, M. C. Fishbein, R. Crystal, and S. S. Gambhir
Molecular Imaging of the Kinetics of Vascular Endothelial Growth Factor Gene Expression in Ischemic Myocardium
Circulation, August 10, 2004; 110(6): 685 - 691.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The Society of Thoracic Surgeons.